-
ExoU, Lipid Metabolism, and Host Cell Death
2026-08-27
The University of Ottawa thesis investigates how the Pseudomonas aeruginosa toxin ExoU connects phospholipase activity, host lipid remodeling, and cytotoxicity. Its most direct mechanistic finding is that ExoU-expressing bacteria increase lysophosphatidylcholine levels in host cells, while pharmacological tests argue against apoptosis or necroptosis as the dominant explanation for early cell death.
-
Nanoparticle Uptake in Human Corneal Epithelium
2026-08-27
This 2024 ACS study systematically links PLGA nanoparticle size and surface chemistry to uptake by human corneal epithelial cells. Using a mucosal in vitro model and pathway inhibitors, it identifies energy-dependent endocytosis, especially macropinocytosis and caveolae-mediated uptake, as the dominant mechanisms.
-
Autophagy–Liver Metastasis Signature in CRC
2026-08-26
Bai et al. integrated bulk and single-cell transcriptomic data to develop a six-gene colorectal cancer signature associated with autophagy, liver metastasis, prognosis, and immune dysfunction. The study links high-risk classification with immunosuppressive macrophage and CD8+ T-cell states, while providing a framework for evaluating treatment response and tumor microenvironment heterogeneity.
-
Neomycin sulfate: Workflow for Structure Studies
2026-08-26
Neomycin sulfate is an aminoglycoside antibiotic that can serve as a mechanistic probe for RNA, DNA, and ion-channel experiments—not merely as a generic antimicrobial. This workflow connects concentration-controlled binding assays with ribozyme, HIV-1 TAR, DNA triplex, and ryanodine receptor applications while emphasizing controls, fresh aqueous preparation, and cross-domain limitations.
-
BIBP 3226 Trifluoroacetate: Cardiac Assays
2026-08-25
BIBP 3226 trifluoroacetate enables pharmacological separation of NPY Y1 and NPFF signaling in cAMP, calcium, and adipose-neural models. This guide translates recent arrhythmia findings into practical workflows, concentration-planning rules, and troubleshooting strategies for cardiovascular, anxiety, and analgesia research.
-
Capsazepine for TRPV1 Ion Channel Research
2026-08-25
Capsazepine is a practical mechanistic probe for separating TRPV1-driven nociception from broader inflammatory and affective pain pathways. This workflow shows how to apply it in calcium imaging, sensory-neuron assays, behavioral models, TRPM8 experiments, and apoptosis studies while controlling for solubility and off-target effects.
-
(R)-MG132 for Proteasome Control
2026-08-24
(R)-MG132 is a functionally inactive MG-132 enantiomer designed to separate proteasome-dependent effects from solvent, peptide-aldehyde, and nonspecific stress responses. Used alongside active MG-132, it adds a rigorous control layer to HNRNPU lactylation, PHGDH regulation, and cancer-metabolism assays.
-
Computational Hapten Design for Dual Toxin Detection
2026-08-24
This 2026 study combines molecular similarity analysis, quantum-chemical calculations, and monoclonal antibody development to create a fluorescent immunochromatographic assay for simultaneous detection of amatoxins and phallotoxins in mushrooms. The resulting assay achieved low nanogram-per-milliliter antibody sensitivities and low microgram-per-kilogram detection limits in mushroom matrices, providing a practical complement to laboratory instrumental analysis.
-
3D Tumor Spheroids for Glioblastoma Stemness
2026-08-23
Chen et al. present a streamlined 96-well 3D-tumor spheroid assay for functional assessment of stem-like phenotypes in glioblastoma cell lines. By replacing a slower two-round sphere-forming workflow with a compact seeding, centrifugation, and imaging procedure, the method supports reproducible mechanistic studies and higher-throughput screening while still requiring orthogonal validation.
-
Neomycin sulfate for RNA, DNA, and Channel Assays
2026-08-22
Neomycin sulfate is an aminoglycoside antibiotic repurposed as a mechanistic probe for structured RNA, DNA triplexes, HIV-1 TAR recognition, and ryanodine receptor conductance. This workflow-focused guide explains how to choose concentrations, separate binding from catalysis, and control matrix effects without confusing exploratory antibiotic exposure with disease-treatment evidence.
-
Xenopus laevis Pluripotency Network Rewiring
2026-08-21
The reference study shows that hybridization rewired early pluripotency regulation in allotetraploid Xenopus laevis through asymmetric activation of homeologous genes and divergent enhancer architectures. Despite this regulatory divergence, combined L- and S-subgenome expression preserves the dosage of core embryonic transcriptional programs, revealing how selection can stabilize development after genome duplication.
-
From Kinases to Condensates: A Translational Playbook
2026-08-21
A mechanistic and strategic framework for using the CK2 and ERK8 inhibitor as a controlled perturbation tool in kinase signaling, protein interaction, and phase-separation research—without overstating an unproven antiviral mechanism.
-
MG-132 (Z-LLL-al) for Proteasome Assays
2026-08-20
MG-132 (Z-LLL-al) provides a cell-permeable way to perturb proteasome-dependent protein turnover while tracking apoptosis, cell cycle arrest, oxidative stress, and mitochondrial quality control. Its most useful application is comparative mechanism testing: pair proteasome inhibition with ubiquitination, LC3, ROS, viability, and mitochondrial readouts rather than treating it as a pathway-specific mitophagy reagent.
-
MCL1 Resistance Biology Meets L1023 Screening
2026-08-20
MCL1-mediated apoptosis resistance is a compelling test case for translating mechanistic oncology findings into pathway-aware screening. This article shows how the DiscoveryProbe™ Anti-cancer Compound Library (SKU: L1023) can support structured comparison of apoptosis, kinase, proteostasis, and mTOR-linked dependencies without mistaking a phenotypic hit for a validated target mechanism.
-
Berbamine Hydrochloride as a Ferroptosis Probe
2026-08-19
Explore how Berbamine hydrochloride can be used as an NF-κB activity inhibitor and experimental perturbation tool in cancer research. This article translates the METTL16-SENP3-LTF ferroptosis findings into practical assay strategies without overclaiming direct pathway targeting.